These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 3128116)

  • 21. In vitro killing of schistosomula of Schistosoma mansoni by BCG and C. parvum-activated macrophages.
    Mahmoud AA; Peters PA; Civil RH; Remington JS
    J Immunol; 1979 May; 122(5):1655-7. PubMed ID: 376723
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Phagocytosis of Mycobacterium leprae by human monocyte-derived macrophages is mediated by complement receptors CR1 (CD35), CR3 (CD11b/CD18), and CR4 (CD11c/CD18) and IFN-gamma activation inhibits complement receptor function and phagocytosis of this bacterium.
    Schlesinger LS; Horwitz MA
    J Immunol; 1991 Sep; 147(6):1983-94. PubMed ID: 1679838
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Studies of the antibody-dependent killing of schistosomula of Schistosoma mansoni employing haptenic target antigens. II. In vitro killing of TNP-schistosomula by human eosinophils and neutrophils.
    Moser G; Sher A
    J Immunol; 1981 Mar; 126(3):1025-9. PubMed ID: 7462624
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Macrophages as effector cells of protective immunity in murine schistosomiasis. III. Loss of susceptibility to macrophage-mediated killing during maturation of S. mansoni schistosomula from the skin to the lung stage.
    Sher A; James SL; Simpson AJ; Lazdins JK; Meltzer MS
    J Immunol; 1982 Apr; 128(4):1876-9. PubMed ID: 7061853
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Macrophage cytotoxicity against schistosomula of Schistosoma mansoni involves arginine-dependent production of reactive nitrogen intermediates.
    James SL; Glaven J
    J Immunol; 1989 Dec; 143(12):4208-12. PubMed ID: 2592772
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Release of leukotriene C4 (LTC4) from human eosinophils following adherence to IgE- and IgG-coated schistosomula of Schistosoma mansoni.
    Moqbel R; Macdonald AJ; Cromwell O; Kay AB
    Immunology; 1990 Mar; 69(3):435-42. PubMed ID: 2312166
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cytokine regulation of human monocyte differentiation in vitro: the tumor-cytotoxic phenotype induced by macrophage colony-stimulating factor is developmentally regulated by gamma-interferon.
    Munn DH; Armstrong E
    Cancer Res; 1993 Jun; 53(11):2603-13. PubMed ID: 8495423
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Species-related innate resistance to Schistosoma mansoni. Role of mononuclear phagocytes in schistosomula killing in vitro.
    Peck CA; Carpenter MD; Mahmoud AA
    J Clin Invest; 1983 Jan; 71(1):66-72. PubMed ID: 6848560
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Killing of Histoplasma capsulatum by gamma-interferon-activated human monocyte-derived macrophages: evidence for a superoxide anion-dependent mechanism.
    Brummer E; Kurita N; Yoshida S; Nishimura K; Miyaji M
    J Med Microbiol; 1991 Jul; 35(1):29-34. PubMed ID: 1649308
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunity to Schistosoma mansoni in guinea-pigs vaccinated with radiation-attenuated cercariae. T-cell activation of macrophages for larval killing.
    Gordon JR; McLaren DJ
    Immunology; 1988 Feb; 63(2):173-80. PubMed ID: 2832308
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Human erythrocytes adhering to schistosomula of Schistosoma mansoni lyse and fail to transfer membrane components to the parasite.
    Caulfield JP; Cianci CM
    J Cell Biol; 1985 Jul; 101(1):158-66. PubMed ID: 4008525
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tumor target-derived soluble factor synergizes with IFN-gamma and IL-2 to activate macrophages for tumor necrosis factor and nitric oxide production to mediate cytotoxicity of the same target.
    Jiang H; Stewart CA; Fast DJ; Leu RW
    J Immunol; 1992 Sep; 149(6):2137-46. PubMed ID: 1517576
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparative sequence analysis reveals regulation of genes in developing schistosomula of Schistosoma mansoni exposed to host portal serum.
    Jeremias WJ; Araújo FMG; Queiroz FR; Pais FSM; Mattos ACA; Salim ACM; Coelho PMZ; Oliveira GC; Kusel JR; Guerra-Sá R; Coimbra RS; Babá ÉH
    PLoS One; 2017; 12(6):e0178829. PubMed ID: 28622369
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Involvement of tumor necrosis factor in cytotoxicity mediated by human monocytes.
    Nissen-Meyer J; Hofsli E; Espevik T; Austgulen R
    Nat Immun Cell Growth Regul; 1988; 7(5-6):266-79. PubMed ID: 3146697
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Interferon gamma fails to activate human monocyte-derived macrophages to kill or inhibit the replication of a non-pathogenic mycobacterial species.
    Robertson AK; Andrew PW
    Microb Pathog; 1991 Oct; 11(4):283-8. PubMed ID: 1813779
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Destruction of the multicellular parasite Schistosoma mansoni by T lymphocytes.
    Ellner JJ; Olds GR; Lee CW; Kleinhenz ME; Edmonds KL
    J Clin Invest; 1982 Aug; 70(2):369-78. PubMed ID: 6980229
    [TBL] [Abstract][Full Text] [Related]  

  • 37. IL-10 synergizes with IL-4 and transforming growth factor-beta to inhibit macrophage cytotoxic activity.
    Oswald IP; Gazzinelli RT; Sher A; James SL
    J Immunol; 1992 Jun; 148(11):3578-82. PubMed ID: 1588047
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interferon-gamma inhibits scavenger receptor expression and foam cell formation in human monocyte-derived macrophages.
    Geng YJ; Hansson GK
    J Clin Invest; 1992 Apr; 89(4):1322-30. PubMed ID: 1556191
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Defective vaccine-induced immunity to Schistosoma mansoni in P strain mice. II. Analysis of cellular responses.
    James SL; Correa-Oliveira R; Leonard EJ
    J Immunol; 1984 Sep; 133(3):1587-93. PubMed ID: 6431002
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparative analysis of the priming effect of human interferon-gamma, -alpha, and -beta on synergism with muramyl dipeptide analog for anti-tumor expression of human blood monocytes.
    Utsugi T; Sone S
    J Immunol; 1986 Feb; 136(3):1117-22. PubMed ID: 3079797
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.